ARWR Arrowhead Pharmaceuticals, Inc. logo

ARWR Arrowhead Pharmaceuticals, Inc.

Healthcare
$78.68+4.98%ClosedMarket Cap: $11.08B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

0

Dispositions

5

Buy/Sell Ratio

0.00

Net Shares

-26,065

Shares Acquired

0

Shares Disposed

26,065

Total Bought ($)

$0.00

Total Sold ($)

$5.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 14Lu HongbodirectorSell2,970$76.8852,012
Fri Apr 24Hamilton James Cofficer: Chief Medical OfficerSell10,000$75.00226,958
Fri Apr 24Apel Daniel Josephofficer: Chief Financial OfficerSell8,730$71.92162,905
Fri Apr 24Apel Daniel Josephofficer: Chief Financial OfficerSell3,208$70.11172,792
Fri Apr 24Apel Daniel Josephofficer: Chief Financial OfficerSell1,157$70.45171,635
Mon Mar 09Hamilton James Cofficer: Chief Medical OfficerSell10,000$64.19236,958
Thu Jan 08O'Brien Patrickofficer: COOSell540$0.00474,368
Thu Jan 08O'Brien Patrickofficer: COOSell440$0.00472,848
Thu Jan 08O'Brien Patrickofficer: COOSell75,000$0.00547,408
Thu Jan 08Hamilton James Cofficer: Chief Medical OfficerSell75,000$0.00246,958
Thu Jan 08Apel Daniel Josephofficer: Chief Financial OfficerSell75,000$0.00176,200
Mon Jan 05O'Brien Patrickofficer: COOSell560$0.00526,641